Skip to main content

Table 5 ICCs and adjusted differences between groups

From: The effectiveness of the Austrian disease management programme for type 2 diabetes: a cluster-randomised controlled trial

 

ICC1 district

ICC1 surgery

adjusted2

  
   

mean difference

95%-CI

p-value

Primary outcome measure

HbA1c (%)

-0.002

0.003

-0.03

[-0.15; 0.09]

0.607

Secondary outcome measures

Creatinine (μmol/l)

0.001

-0.001

-0.96

[-4.16; 2.20]

0.545

Triglycerides (mmol/l)

-0.002

0.003

-0.10

[-0.24; 0.05]

0.190

Cholesterol (mmol/l)

-0.001

0.006

-0.10

[-0.21; -0.003]

0.043

HDL (mmol/l)

0.002

0.048

-0.01

[-0.05; 0.02]

0.438

LDL (mmol/l)

0.007

0.046

-0.02

[-0.10; 0.07]

0.684

RR systolic (mmHg)

0.002

0.054

-0.50

[-2.06; 1.05]

0.524

RR diastolic (mmHg)

0.009

0.045

-0.13

[-1.03; 0.76]

0.770

BMI

-0.001

0.020

-0.53

[-1.03; -0.02]

0.040

  1. 1 calculated with GEE
  2. 2 mixed models adjusted for baseline value and cluster structure